Develops bispecific antibodies and antibody-drug conjugates for cancer and neurodegenerative diseases.
2016
South Korea
51 - 200 employees
Biotechnology
$25M - 100M in revenue
Institutions excluding by region out of total tracked institutions
Institution name, type, screener label
Powered by illuminem and CovalenceNot reporting on Sustainability